BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240208T130000
DTEND;TZID=America/New_York:20240208T150000
DTSTAMP:20260410T095614
CREATED:20240111T141714Z
LAST-MODIFIED:20241024T183000Z
UID:10000718-1707397200-1707404400@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 120-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-8/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9785_QDI_IPA_GI545875183_16x9_54188_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240213T130000
DTEND;TZID=America/New_York:20240213T143000
DTSTAMP:20260410T095614
CREATED:20240111T143538Z
LAST-MODIFIED:20241024T183001Z
UID:10000719-1707829200-1707834600@staging.digitalinsights.supremeclients.com
SUMMARY:Long reads analysis using CLC Genomics workbench (with new features - 2024)
DESCRIPTION:This webinar will introduce users to the long read support plugin for Oxford Nanopore and PacBio sequencing reads in QIAGEN CLC Genomics Workbench. \nParticipants will learn the following: \n• Download and install needed plugins.\n• Import data required for the analysis.\n• Long read de novo assembly.\n• Map reads to a reference and visualize an assembly.\n• Use BLAST to investigate the contigs.\n• Additional long read tools: polish with short reads\, structural variant calling.\n• Genome finishing tools: analyze and assemble contigs\n• Analytical tools: RNA-seq analysis for long reads\, classify long read amplicons for metagenomics.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/long-reads-analysis-using-clc-genomics-workbench-with-new-features-2024/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1108_8_QDI_CLC_Challenger_Or54963_16x9_56810_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240214T100000
DTEND;TZID=America/New_York:20240214T110000
DTSTAMP:20260410T095614
CREATED:20240111T164231Z
LAST-MODIFIED:20241024T183002Z
UID:10000720-1707904800-1707908400@staging.digitalinsights.supremeclients.com
SUMMARY:Introduction to Analysis Match in IPA - Compare your gene and protein expression data to over 100.000 published experimental data
DESCRIPTION:With all the expression datasets that are available to the public\, wouldn’t it be great to compare them to your own expression data\, so you could get a better understanding of the underlying biology of your data? \nWith QIAGEN IPA Analysis Match\, you can compare your expression data with well over 100\,000 publicly available datasets that have been processed and analyzed in IPA\, as well as all the IPA analyses that you have performed to date. \nIn this webinar\, we will cover how Analysis Match works and demonstrate this feature with a live demonstration. Feel free to follow along with your analysis and ask questions along the way!
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/introduction-to-analysis-match-in-ipa-compare-your-gene-and-protein-expression-data-to-over-100-000-published-experimental-data-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240214T160000
DTEND;TZID=Europe/Paris:20240214T170000
DTSTAMP:20260410T095614
CREATED:20240111T164643Z
LAST-MODIFIED:20241024T183003Z
UID:10000721-1707926400-1707930000@staging.digitalinsights.supremeclients.com
SUMMARY:Introduction to Analysis Match in IPA - Compare your gene and protein expression data to over 100.000 published experimental data
DESCRIPTION:With all the expression datasets that are available to the public\, wouldn’t it be great to compare them to your own expression data\, so you could get a better understanding of the underlying biology of your data? \nWith QIAGEN IPA Analysis Match\, you can compare your expression data with well over 100\,000 publicly available datasets that have been processed and analyzed in IPA\, as well as all the IPA analyses that you have performed to date. \nIn this webinar\, we will cover how Analysis Match works and demonstrate this feature with a live demonstration. Feel free to follow along with your analysis and ask questions along the way!
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/introduction-to-analysis-match-in-ipa-compare-your-gene-and-protein-expression-data-to-over-100-000-published-experimental-data-2-2/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240215T080000
DTEND;TZID=UTC:20240215T170000
DTSTAMP:20260410T095614
CREATED:20260410T095614Z
LAST-MODIFIED:20241024T183022Z
UID:10000730-1707984000-1708016400@staging.digitalinsights.supremeclients.com
SUMMARY:Single Cell RNA-Seq\, Cell Hashing\, and Spatial Transcriptomics
DESCRIPTION:In this training\, you will learn how to analyze and interpret your own single-cell RNA-seq data using QIAGEN CLC Genomics Workbench starting with either FASTQ or matrix files. \nUsing CLC Genomics Workbench\, you will learn how to perform secondary analysis on your single-cell RNA-seq data. Specifically\, you will learn how to:\n• Import your raw FASTQ or processed cell-matrix files.\n• Use pre-configured but customizable pipelines/workflows for single-cell RNA-seq data.\n• Generate high-resolution visuals and other files from your analysis for publications and biopharmaceutical discoveries.\no Dimension reduction (UMAP\, t-SNE) plots\no Differential expression table for clusters\, cell types\, or a combination of both\no Heat map\no Dot plots\no Violin plots\n• Learn how to use “Create Cell Annotations from Hashtags” for cell hashing (i.e.\, CITE-seq).\n• Dive into spatial transcriptomic analysis\, the latest feature in the single cell RNA-seq module.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/single-cell-rna-seq-cell-hashing-and-spatial-transcriptomics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T130000
DTEND;TZID=America/New_York:20240215T143000
DTSTAMP:20260410T095614
CREATED:20240215T173235Z
LAST-MODIFIED:20241024T183022Z
UID:10000729-1708002000-1708007400@staging.digitalinsights.supremeclients.com
SUMMARY:ATCC cell line data utilization for cell line selection\, validation and other applications
DESCRIPTION:Cancer cell line models have been a cornerstone of cancer research for decades. Profiling cancer cell lines can be a powerful tool to identify gene alterations or cancer-related pathways and aid in discovering putative drug targets. In this webinar\, we'll use QIAGEN OmicSoft Lands and QIAGEN Ingenuity Pathway Analysis (IPA) to help you select cell lines and translate insights from your cell line experiments for drug target discovery. \nDuring this 90-minute discussion\, we'll explore how you can use these software tools to:\n• Select appropriate cancer cell lines for a variety of applications such as drug discovery\, precision disease modeling\, understanding gene function in cancer\, immune-oncology research and more\n• Examine various 'omics data for genes of interest for expression\, mutation\, hotspots and gene dependency data\n• Generate networks for hypotheses and test them in silico to improve the translation of insights derived from cell line models to the drug target identification\n• Integrate analyses of public 'omics data and drug response phenotypes using cell line model systems by exploring data from the Library of Integrated Network-Based Cellular Signatures (LINCS)\n• Prioritize drug targets and profile phenotypic/downstream effects of drug action by overlaying public data on user-generated networks \nOur system uses millions of curated literature findings from QIAGEN Knowledge Base and the OmicSoft digital warehouse. This discussion is intended for both those familiar with QIAGEN IPA and newcomers interested in learning more.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/atcc-cell-line-data-utilization-for-cell-line-selection-validation-and-other-applications/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1276_1_QDI_QDI_ATCC_Generic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240220T130000
DTEND;TZID=America/New_York:20240220T143000
DTSTAMP:20260410T095614
CREATED:20240111T165213Z
LAST-MODIFIED:20241024T183004Z
UID:10000722-1708434000-1708439400@staging.digitalinsights.supremeclients.com
SUMMARY:Mining curated knowledge graphs and validating with experimental datasets to accelerate your drug target discovery
DESCRIPTION:In an era of near-limitless public experimental data but little standardization\, meaningful insights are lost to noise. Large collections of quality experimental data are essential for big-picture discoveries that stand up to scrutiny. \nIn this webinar\, you will learn how to feed your drug discovery programs by integrating connections mined from QIAGEN Biomedical Knowledge Base with deeply curated disease datasets from QIAGEN OmicSoft Lands. \nCombining unified 'omics datasets with contextual relationship evidence from our knowledge graph\, we will address complex questions such as:   \n\n Which genes aren't expressed in normal tissue\, yet are expressed in diseases of interest\, based on experimental evidence?\n Which of these proteins are cell surface proteins\, with evidence for extracellular localization?\n How are these proteins related directly or indirectly to disease pathways\, and can these be connected to known drug targets?\n Can we identify correlated biomarkers\, mutation targets\, clinical factors or other means of cohort selection?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/mining-curated-knowledge-graphs-and-validating-with-experimental-datasets-to-accelerate-your-drug-target-discovery/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240221T090000
DTEND;TZID=America/New_York:20240221T100000
DTSTAMP:20260410T095614
CREATED:20240207T213516Z
LAST-MODIFIED:20241024T183019Z
UID:10000727-1708506000-1708509600@staging.digitalinsights.supremeclients.com
SUMMARY:How biopharmaceutical companies can leverage expert-curated knowledge from Wellcome Sanger Institute and QIAGEN to accelerate cancer drug discovery and development
DESCRIPTION:The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity\, the pace of development has never been faster. Biopharmaceutical companies can’t afford to waste time and resources pursuing ineffective or unsafe ideas. \nIn this talk\, our experts discuss how biopharmaceutical companies can leverage key genomic\, biomedical\, and clinical trial databases to improve and accelerate cancer drug discovery while avoiding potential pitfalls. Through a series of use cases\, attendees will learn about expert-curated knowledge from the Wellcome Sanger Institute and QIAGEN\, and how to use these resources to better predict cancer-driving effects of mutations\, identify available drugs that target specific variants\, and accelerate indication expansion and repurposing of existing cancer therapies. \nLearning objectives: \n1. Examine use-cases of how to leverage expert-curated databases across multiple phases of cancer drug development. \n2. Discover key applications of these databases\, including determining the function\, frequency\, and actionability of specific mutations. \n3. Discuss potential pitfalls and clinical consequences\, and how to avoid them early with data-driven drug target and biomarker qualification.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-biopharmaceutical-companies-can-leverage-expert-curated-knowledge-from-wellcome-sanger-institute-and-qiagen-to-accelerate-cancer-drug-discovery-and-development/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1366_2_QDI_QCI_HSMDvsCOSMIC_Biopharmam.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240227T130000
DTEND;TZID=America/New_York:20240227T143000
DTSTAMP:20260410T095614
CREATED:20240111T165729Z
LAST-MODIFIED:20241024T183004Z
UID:10000723-1709038800-1709044200@staging.digitalinsights.supremeclients.com
SUMMARY:Public single-cell RNA-seq data investigation using QIAGEN Omicsoft and Ingenuity Pathway Analysis
DESCRIPTION:Single-cell RNA-sequencing (scRNA-seq) is widely used to investigate tissue heterogeneity\, identify novel cell types\, study pathogenic mechanisms\, develop targeted therapy (including immunotherapy) and more. Accordingly\, a tremendous amount of scRNA-seq data has been deposited to public domains like GEO.  In this training\, you will learn how to  · Locate public single-cell studies of interest using QIAGEN Omicsoft Single-Cell Lands  · Study different cell types by dimension reduction plots (for example\, t-SNE\, UMAP)  · Investigate expression of genes of interest across different cell types (Violin plots\, overlay expression on cluster)  · Identify key pathways and regulators from scRNA-seq data using QIAGEN Ingenuity Pathway Analysis (IPA) 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/public-single-cell-rna-seq-data-investigation-using-qiagen-omicsoft-and-ingenuity-pathway-analysis-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1064_1_OmicSoft-Single-Cell-Lands_029541_Large-1200px_54944.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240229T130000
DTEND;TZID=America/New_York:20240229T143000
DTSTAMP:20260410T095614
CREATED:20240229T104537Z
LAST-MODIFIED:20241024T183027Z
UID:10000736-1709211600-1709217000@staging.digitalinsights.supremeclients.com
SUMMARY:Biomarker discovery\, target validation\, and variant identification using QIAGEN OmicSoft DiseaseLand\, Human Gene Mutation Database\, and Ingenuity Pathway Analysis
DESCRIPTION:In this webinar\, users will learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers\, validate targets\, and identify variants. Specifically\, users will learn:\n1. How to locate public studies of interest using OmicSoft DiseaseLand.\n2. Investigate the expression of genes of interest across different treatments\, disease states\, etc.\n3. Identify variants of interest for candidate biomarkers and targets using the Human Gene Mutation Database.\n4. Leveraging the QIAGEN Knowledgebase in Ingenuity Pathway Analysis to explore and extend findings from OmicSoft DiseaseLand and Human Gene Mutation Database.\n5. Learn about additional methods to access data from OmicSoft\, Human Gene Mutation Database\, and Ingenuity Pathway Analysis for data scientists.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/biomarker-discovery-target-validation-and-variant-identification-using-qiagen-omicsoft-diseaseland-human-gene-mutation-database-and-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/ILLU_1851_QDI_QDI_biomedical_knowledge_base-1.jpg
END:VEVENT
END:VCALENDAR